glp-1 news november 6 2025 Weight-loss drug makers announce pricing agreement with Trump Medicare $50 GLP-1 Weight Loss
Description
There is going to be growing pressure to cover obesity drugs, so this is not an issue that the incoming administration can easily just sidestep, Larry Levitt, EVP for health policy at KFF, told Healthcare Brew
An update on SGLT2 inhibitors for the treatment of diabetes mellitus
This article is written for a general adult consumer audience and intends statements to be interpreted as a reasonable consumer would interpret them in context
The Research Behind This Article: Chowdhury et al
would likely cause prices elsewhere to rise, which may seem like an improvement in equality
